BG
Bellevue Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14M | Sell |
26,744
-1,779
| -6% | -$934K | 0.31% | 58 |
|
2025
Q1 | $18.1M | Sell |
28,523
-2,889
| -9% | -$1.83M | 0.41% | 53 |
|
2024
Q4 | $22.4M | Buy |
31,412
+4,636
| +17% | +$3.3M | 0.43% | 57 |
|
2024
Q3 | $28.1M | Sell |
26,776
-5,521
| -17% | -$5.8M | 0.46% | 64 |
|
2024
Q2 | $33.9M | Buy |
32,297
+25,220
| +356% | +$26.5M | 0.55% | 52 |
|
2024
Q1 | $6.81M | Sell |
7,077
-3,632
| -34% | -$3.5M | 0.1% | 92 |
|
2023
Q4 | $9.41M | Sell |
10,709
-4,230
| -28% | -$3.72M | 0.14% | 88 |
|
2023
Q3 | $12.3M | Sell |
14,939
-1,388
| -9% | -$1.14M | 0.2% | 84 |
|
2023
Q2 | $11.7M | Buy |
16,327
+1,011
| +7% | +$726K | 0.17% | 91 |
|
2023
Q1 | $12.6M | Sell |
15,316
-362
| -2% | -$297K | 0.18% | 90 |
|
2022
Q4 | $11.3M | Sell |
15,678
-1,711
| -10% | -$1.23M | 0.15% | 95 |
|
2022
Q3 | $12M | Sell |
17,389
-338
| -2% | -$233K | 0.17% | 96 |
|
2022
Q2 | $10.5M | Sell |
17,727
-72,553
| -80% | -$42.9M | 0.15% | 104 |
|
2022
Q1 | $63.1M | Sell |
90,280
-2,780
| -3% | -$1.94M | 0.73% | 47 |
|
2021
Q4 | $58.8M | Sell |
93,060
-13,350
| -13% | -$8.43M | 0.61% | 55 |
|
2021
Q3 | $64.4M | Buy |
106,410
+750
| +0.7% | +$454K | 0.65% | 49 |
|
2021
Q2 | $59M | Buy |
105,660
+69,860
| +195% | +$39M | 0.58% | 59 |
|
2021
Q1 | $16.9M | Buy |
35,800
+8,100
| +29% | +$3.83M | 0.18% | 105 |
|
2020
Q4 | $13.4M | Buy |
27,700
+7,700
| +39% | +$3.72M | 0.15% | 110 |
|
2020
Q3 | $11.2M | Sell |
20,000
-3,100
| -13% | -$1.74M | 0.15% | 105 |
|
2020
Q2 | $14.4M | Buy |
23,100
+4,000
| +21% | +$2.49M | 0.2% | 93 |
|
2020
Q1 | $9.33M | Sell |
19,100
-2,900
| -13% | -$1.42M | 0.18% | 90 |
|
2019
Q4 | $8.26M | Buy |
+22,000
| New | +$8.26M | 0.13% | 101 |
|
2019
Q2 | – | Sell |
-20,400
| Closed | -$8.38M | – | 212 |
|
2019
Q1 | $8.38M | Buy |
20,400
+5,200
| +34% | +$2.14M | 0.46% | 62 |
|
2018
Q4 | $5.68M | Sell |
15,200
-10,280
| -40% | -$3.84M | 0.37% | 63 |
|
2018
Q3 | $10.3M | Buy |
25,480
+8,220
| +48% | +$3.32M | 0.65% | 49 |
|
2018
Q2 | $5.96M | Sell |
17,260
-10,120
| -37% | -$3.49M | 0.51% | 53 |
|
2018
Q1 | $9.43M | Sell |
27,380
-420
| -2% | -$145K | 0.93% | 42 |
|
2017
Q4 | $10.5M | Sell |
27,800
-2,400
| -8% | -$902K | 1.09% | 36 |
|
2017
Q3 | $13.5M | Buy |
30,200
+2,100
| +7% | +$939K | 1.41% | 23 |
|
2017
Q2 | $13.8M | Sell |
28,100
-1,200
| -4% | -$589K | 1.63% | 18 |
|
2017
Q1 | $11.4M | Sell |
29,300
-3,000
| -9% | -$1.16M | 1.51% | 25 |
|
2016
Q4 | $11.9M | Sell |
32,300
-5,700
| -15% | -$2.09M | 2.43% | 12 |
|
2016
Q3 | $15.3M | Buy |
38,000
+8,000
| +27% | +$3.22M | 2.76% | 7 |
|
2016
Q2 | $10.5M | Sell |
30,000
-2,400
| -7% | -$838K | 1.97% | 14 |
|
2016
Q1 | $11.7M | Buy |
+32,400
| New | +$11.7M | 2.12% | 12 |
|